Convergence Investment Partners, LLC Pfizer Inc Transaction History

Convergence Investment Partners, LLC

$365 Million
Q3 2024

A detailed history of Convergence Investment Partners, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Convergence Investment Partners, LLC holds 13,880 shares of PFE stock, worth $352,135. This represents 0.11% of its overall portfolio holdings.

Number of Shares

13,880

Previous 19,134 27.46%

Holding current value

$352,135

Previous $535,000 25.05%

% of portfolio

0.11%

Previous 0.16%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$27.7 - $31.39 $145,535 - $164,923	-5,254 Reduced 27.46%	13,880 $401,000
Q2 2024 Aug 01, 2024	BUY	$25.26 - $29.6 $162,952 - $190,949	6,451 Added 50.86%	19,134 $535,000
Q1 2024 May 03, 2024	SELL	$25.89 - $29.73 $43,055 - $49,440	-1,663 Reduced 11.59%	12,683 $352,000
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $203,317 - $264,087	-7,781 Reduced 35.17%	14,346 $413,000
Q3 2023 Nov 02, 2023	BUY	$32.09 - $37.51 $149,411 - $174,646	4,656 Added 26.65%	22,127 $734,000
Q2 2023 Jul 26, 2023	BUY	$36.12 - $41.79 $195,553 - $226,251	5,414 Added 44.9%	17,471 $641,000
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $8,114 - $10,563	-206 Reduced 1.68%	12,057 $492,000
Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $278,597 - $363,678	-6,673 Reduced 35.24%	12,263 $628,000
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $2.17 Million - $2.65 Million	-49,594 Reduced 72.37%	18,936 $829,000
Q2 2022 Aug 05, 2022	BUY	$46.53 - $55.17 $81,101 - $96,161	1,743 Added 2.61%	68,530 $3.59 Million
Q1 2022 Apr 26, 2022	BUY	$45.75 - $56.69 $125,446 - $155,443	2,742 Added 4.28%	66,787 $3.46 Million
Q4 2021 Jan 25, 2022	SELL	$41.32 - $61.25 $102,267 - $151,593	-2,475 Reduced 3.72%	64,045 $3.78 Million
Q3 2021 Oct 25, 2021	BUY	$39.25 - $50.42 $176,468 - $226,688	4,496 Added 7.25%	66,520 $2.86 Million
Q2 2021 Jul 19, 2021	BUY	$35.91 - $40.68 $455,841 - $516,391	12,694 Added 25.73%	62,024 $2.43 Million
Q1 2021 Apr 30, 2021	SELL	$33.49 - $37.77 $249,031 - $280,857	-7,436 Reduced 13.1%	49,330 $1.79 Million
Q4 2020 Feb 05, 2021	SELL	$33.47 - $42.56 $656,882 - $835,282	-19,626 Reduced 25.69%	56,766 $2.09 Million
Q3 2020 Oct 28, 2020	BUY	$31.75 - $37.25 $1.96 Million - $2.3 Million	61,837 Added 424.85%	76,392 $2.8 Million
Q2 2020 Jul 30, 2020	SELL	$30.12 - $36.54 $1.64 Million - $1.99 Million	-54,575 Reduced 78.95%	14,555 $476,000
Q1 2020 Apr 23, 2020	SELL	$27.03 - $38.62 $1.53 Million - $2.19 Million	-56,737 Reduced 45.08%	69,130 $2.26 Million
Q4 2019 Jan 22, 2020	BUY	$32.92 - $37.36 $1.02 Million - $1.15 Million	30,836 Added 32.45%	125,867 $4.93 Million
Q3 2019 Oct 22, 2019	SELL	$32.49 - $42.13 $847,436 - $1.1 Million	-26,083 Reduced 21.54%	95,031 $3.41 Million
Q2 2019 Jul 23, 2019	SELL	$36.98 - $41.52 $2.33 Million - $2.61 Million	-62,926 Reduced 34.19%	121,114 $5.25 Million
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $318,712 - $350,158	-8,499 Reduced 4.41%	184,040 $7.82 Million
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $463,871 - $528,863	-12,058 Reduced 5.89%	192,539 $8.4 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $4.16 Million - $5.05 Million	-120,674 Reduced 37.1%	204,597 $9.02 Million
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $773,974 - $825,134	23,468 Added 7.78%	325,271 $11.8 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $5.23 Million - $6.06 Million	163,749 Added 118.61%	301,803 $10.7 Million
Q4 2017 Jan 16, 2018	SELL	$33.26 - $35.29 $244,793 - $259,734	-7,360 Reduced 5.06%	138,054 $5 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $4.51 Million - $4.97 Million	145,414	145,414 $5.19 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $142B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Convergence Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Convergence Investment Partners, LLC with notifications on news.

Account

Convergence Investment Partners, LLC Pfizer Inc Transaction History